The effect of Bcl-2 siRNA combined with miR-15a oligonucleotides on the growth of Raji cells (Q39212627)

10 September 2017

title

The effect of Bcl-2 siRNA combined with miR-15a oligonucleotides on the growth of Raji cells (English)

1 reference

10 September 2017

Xiaomao Hu

1 reference

10 September 2017

Wenyu Li

1 reference

10 September 2017

Gexiu Liu

1 reference

10 September 2017

Hong Wu

1 reference

10 September 2017

Yangjun Gao

1 reference

10 September 2017

Shengting Chen

1 reference

10 September 2017

Dongmei He

1 reference

10 September 2017

Yuan Zhang

1 reference

10 September 2017

publication date

10 January 2013

1 reference

10 September 2017

1 reference

10 September 2017

1 reference

10 September 2017

1 reference

10 September 2017

page(s)

430

1 reference

MicroRNA signatures in human cancers

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0430-6

Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0430-6

Widespread changes in protein synthesis induced by microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0430-6

microRNAs as oncogenes and tumor suppressors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0430-6

Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0430-6

A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0430-6

miR-15 and miR-16 induce apoptosis by targeting BCL2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0430-6

MiR-15a and miR-16-1 cluster functions in human leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0430-6

Oblimersen Bcl-2 antisense: facilitating apoptosis in anticancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0430-6

The role of Bcl-2 family members in tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0430-6

RNA interference is a functional pathway with therapeutic potential in human myeloid leukemia cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0430-6

Small hairpin RNA targeting at Bcl-2 increases cytarabine-induced apoptosis in Raji cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0430-6

miR-15a and miR-16-1 inhibit the proliferation of leukemic cells by down-regulating WT1 protein level

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0430-6

Analyzing real-time PCR data by the comparative C(T) method

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0430-6

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0430-6

Curcumin induced nanoscale CD44 molecular redistribution and antigen-antibody interaction on HepG2 cell surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0430-6

Cell‐surface ultrastructural changes during the in vitro neuron‐like differentiation of rat bone marrow‐derived mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0430-6

MicroRNAs in biological processes and carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0430-6

miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0430-6

The future of antisense therapy: combination with anticancer treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0430-6

The effect of lentivirus-mediated expression of tumor necrosis factor related apoptosis-inducing ligand and shRNA against Bcl-2 on the growth of lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0430-6

Synergistic apoptosis induction in leukemic cells by miR-15a/16-1 and arsenic trioxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0430-6

Inhibition of hepatitis C virus replication by single and dual small interfering RNA using an HCV-infected cell model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0430-6

AFM membrane roughness as a probe to identify oxidative stress-induced cellular apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0430-6

AFM-detected apoptotic changes in morphology and biophysical property caused by paclitaxel in Ishikawa and HeLa cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0430-6

Promises and challenges of targeting Bcl-2 anti-apoptotic proteins for cancer therapy

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23307249

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S12032-012-0430-6

1 reference

10 September 2017

1 reference